AME
75
3
SRE
47
2
PEP
32
-3
ROST
68
-3
EXR
26
2
HAL
54
4
FOXA
66
2
LEN
21
-9
GT
39
-3
ALLE
46
2
INTC
40
-3
SCHW
67
3
NTAP
56
-3
WYNN
48
-2
C
84
2
FE
50
2
BWA
55
2
ETN
57
2
SBUX
40
-4
HIG
70
2
AME
75
3
SRE
47
2
PEP
32
-3
ROST
68
-3
EXR
26
2
HAL
54
4
FOXA
66
2
LEN
21
-9
GT
39
-3
ALLE
46
2
INTC
40
-3
SCHW
67
3
NTAP
56
-3
WYNN
48
-2
C
84
2
FE
50
2
BWA
55
2
ETN
57
2
SBUX
40
-4
HIG
70
2
Financhill
Back

iShares 1-5 Year U.S. IG Corp Bd Idx ETF CAD Hdg Vs. Lyell Immunopharma, Inc. Industry Stock Comparison

Sell
34

XIGS.TO
iShares 1-5 Year U.S. IG Corp Bd Idx ETF CAD Hdg

Last Price:
$37.52
Seasonality Move:
0.71%
Buy
64

LYEL
Lyell Immunopharma, Inc.

Last Price:
$37.17
Seasonality Move:
-16.78%
Sell
34
iShares 1-5 Year U.S. IG Corp Bd Idx ETF CAD Hdg (XIGS.TO) is a Sell

Is iShares 1-5 Year U.S. IG Corp Bd Idx ETF CAD Hdg a Buy, Sell or Hold?

  • The current iShares 1-5 Year U.S. IG Corp Bd Idx ETF CAD Hdg [XIGS.TO] share price is $37.52. The Score for XIGS.TO is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • XIGS.TO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
64
Lyell Immunopharma, Inc. (LYEL) is a Buy

Is Lyell Immunopharma, Inc. a Buy, Sell or Hold?

  • The current Lyell Immunopharma, Inc. [LYEL] share price is $37.37. The Score for LYEL is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
  • LYEL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

XIGS.TO Stock Price Chart

What is iShares 1-5 Year U.S. IG Corp Bd Idx ETF CAD Hdg's stock price today?

  • The iShares 1-5 Year U.S. IG Corp Bd Idx ETF CAD Hdg share price today is $37.52
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and XIGS.TO is experiencing selling pressure, which indicates risk of future bearish movement.

LYEL Stock Price Chart

What is Lyell Immunopharma, Inc.'s stock price today?

  • The Lyell Immunopharma, Inc. share price today is $37.37
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LYEL is experiencing slight selling pressure.

XIGS.TO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 8.35 Buy
Relative Strength Index (14 RSI): 49.99 Sell
Chaikin Money Flow: -6403 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (37.44 - 37.56) Buy
Bollinger Bands (100): (37.5 - 37.7) Sell

LYEL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.08 Buy
Relative Strength Index (14 RSI): 79.16 Buy
Chaikin Money Flow: -97373 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (20.11 - 32.35) Buy
Bollinger Bands (100): (10.77 - 23.75) Buy

XIGS.TO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 37.52 Sell
20-day SMA: 37.52 Buy
50-day SMA: 37.56 Sell
200-day SMA: 37.47 Buy
8-day EMA: 23.8 Buy
20-day EMA: 12.38 Buy
50-day EMA: 5.55 Buy
200-day EMA: 1.47 Buy

LYEL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 33.51 Buy
20-day SMA: 28.33 Buy
50-day SMA: 21.67 Buy
200-day SMA: 13.52 Buy
8-day EMA: 33.02 Buy
20-day EMA: 28.99 Buy
50-day EMA: 23.45 Buy
200-day EMA: 17.42 Buy

iShares 1-5 Year U.S. IG Corp Bd Idx ETF CAD Hdg Earnings Growth & XIGS.TO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Lyell Immunopharma, Inc. Earnings Growth & LYEL Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $9.86 per share, and a decrease next year of $3.96 per share.

iShares 1-5 Year U.S. IG Corp Bd Idx ETF CAD Hdg Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Lyell Immunopharma, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):